<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4798073</article-id><article-id pub-id-type="publisher-id">566</article-id><article-id pub-id-type="doi">10.1186/2197-425X-3-S1-A422</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>An international phase iii randomised trial on the efficacy of helium/oxygen during spontaneous breathing and intermittent non-invasive ventilation for severe exacerbations of chronic obstructive pulmonary disease (the E.C.H.O.<sup>ICU</sup>trial)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Jolliet</surname><given-names>P</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Besbes</surname><given-names>L</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Abroug</surname><given-names>F</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Ben Kheli</surname><given-names>J</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Besbes</surname><given-names>M</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Arnal</surname><given-names>J-M</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Daviaud</surname><given-names>F</given-names></name><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Chiche</surname><given-names>J-D</given-names></name><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Lortat-Jacob</surname><given-names>B</given-names></name><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Diehl</surname><given-names>J-L</given-names></name><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Lerolle</surname><given-names>N</given-names></name><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Mercat</surname><given-names>A</given-names></name><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Razazi</surname><given-names>K</given-names></name><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>Brun-Buisson</surname><given-names>C</given-names></name><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>Bertini</surname><given-names>S</given-names></name><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Corrado</surname><given-names>A</given-names></name><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Texereau</surname><given-names>J</given-names></name><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author"><name><surname>Brochard</surname><given-names>L</given-names></name><xref ref-type="aff" rid="Aff11"/></contrib><aff id="Aff1"><label/>Intensive Care and Burn Unit - CHUV, Lausanne, Switzerland </aff><aff id="Aff2"><label/>Fattouma Bourguiba University Hospital, Ariana, Tunisia </aff><aff id="Aff3"><label/>Abderrahmen Mami Hospital, Monastir, Tunisia </aff><aff id="Aff4"><label/>Font-Pr&#x000e9; Hospital, Toulon, France </aff><aff id="Aff5"><label/>Cochin Hospital, Paris, France </aff><aff id="Aff6"><label/>Georges Pompidou European Hospital, Paris, France </aff><aff id="Aff7"><label/>Angers University Hospital, Angers, France </aff><aff id="Aff8"><label/>Henri-Mondor Hospital, Paris, France </aff><aff id="Aff9"><label/>Careggi University Hospital, Florence, Italy </aff><aff id="Aff10"><label/>Air Liquide Sant&#x000e9; International, Paris, France </aff><aff id="Aff11"><label/>St Michael's Hospital-University Toronto, Toronto, Canada </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2015</year></pub-date><volume>3</volume><issue>Suppl 1</issue><issue-sponsor>The publication charges for this supplement were funded by Intensive Care Medicine Experimental.</issue-sponsor><elocation-id>A422</elocation-id><permissions><copyright-statement>&#x000a9; Jolliet et al.; 2015</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><conference><conf-name>ESICM LIVES 2015</conf-name><conf-loc>Berlin, Germany</conf-loc><conf-date>3-7 October 2015</conf-date><string-conf><uri>http://www.esicm.org/</uri></string-conf></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Due to its reduced density, Helium/Oxygen (He/O<sub>2</sub>) reduces the work of breathing, intrinsic PEEP and hypercapnia more than Air/O<sub>2</sub> during non-invasive ventilation (NIV) in COPD exacerbations [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR1">2</xref>]. Two prospective, randomized multicenter trials were inconclusive in showing a benefit of He/O<sub>2</sub> NIV on outcome (intubation, mortality, length of stay (LOS) in ICU) but were potentially underpowered [<xref ref-type="bibr" rid="CR1">3</xref>, <xref ref-type="bibr" rid="CR1">4</xref>].</p></sec><sec id="Sec2"><title>Objectives</title><p>To evaluate whether 72-hr continuous He/O<sub>2</sub> during both spontaneous breathing and NIV is superior to Air/O<sub>2</sub> in reducing NIV failure (intubation or mortality during ICU stay) in severe hypercapnic COPD exacerbations. Secondary outcomes included physiological parameters, duration of ventilation, ICU and hospital LOS, 6-month recurrence and rehospitalization rates.</p></sec><sec id="Sec3"><title>Methods</title><p>Prospective, randomized multicenter (16 centers in 6 countries) trial, comparing the two gas mixtures for a maximum of 72 hours. Hypothesis was that He/O<sub>2</sub> would reduce intubation rate from 25% to 15%, resulting in a total sample size of 670 patients. Spontaneous breathing and NIV were applied with specific devices for He/O<sub>2</sub>. Same ventilator was used in both arms.</p></sec><sec id="Sec4"><title>Results</title><p>The trial was stopped prematurely for futility (low intubation rate reported by the adjudication committee). 445 patients were included (mean &#x000b1; SD 68 &#x000b1; 11 yrs; M:F 69:31%; BMI 26 &#x000b1; 6 kg/m<sup>2</sup>; SAPS 3 49 &#x000b1; 8; Resp rate (RR) 29 &#x000b1; 6/min - PaO<sub>2</sub> 75 &#x000b1; 36 mmHg; PaCO<sub>2</sub> 69 &#x000b1; 16 mmHg; pH 7.30 &#x000b1; 0.06 - intention-to-treat data set), with no baseline difference between He/O<sub>2</sub> vs. Air/O<sub>2</sub>. The primary outcome was negative (Figure <xref rid="Fig1" ref-type="fig">1</xref>) and baseline pH was the only significant predictor of NIV failure. NIV failure occurred in the first 72 hours (while receiving the study treatment) in 58% of failures with He/O<sub>2</sub> and 84% with Air/O<sub>2</sub> (p = 0.97). RR (Figure <xref rid="Fig2" ref-type="fig">2</xref>), pH, PaCO<sub>2</sub> and encephalopathy improved faster and with greater magnitude with He/O<sub>2</sub><fig id="Fig1"><caption><p>Figure 1</p></caption><graphic xlink:href="40635_2015_Article_566_Fig1_HTML" id="d30e432"/></fig><fig id="Fig2"><caption><p>Figure 2</p></caption><graphic xlink:href="40635_2015_Article_566_Fig2_HTML" id="d30e439"/></fig></p></sec><sec id="Sec5"><title>Conclusions</title><p>NIV failure rate was not reduced by He/O<sub>2</sub> administered during NIV and spontaneous breathing for up to 72 hrs. Failure rate was low in both groups, reflecting the current efficacy of NIV in decompensated COPD. However, He/O<sub>2</sub> led to improved physiological response, thus confirming previous results, and a shorter duration of invasive ventilation and ICU stay in patients with NIV failure.</p></sec><sec id="Sec6"><title>Grant Acknowledgment</title><p>ClinicalTrials.gov Identifier: NCT01155310. Study funded by Air Liquide Healthcare.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaber</surname><given-names>S</given-names></name><name><surname>Fodil</surname><given-names>R</given-names></name><name><surname>Carlucci</surname><given-names>A</given-names></name><name><surname>Boussarsar</surname><given-names>M</given-names></name><name><surname>Pigeot</surname><given-names>J</given-names></name><name><surname>Lemaire</surname><given-names>F</given-names></name><etal/></person-group><article-title>Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>161</volume><fpage>1191</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.161.4.9904065</pub-id><pub-id pub-id-type="pmid">10764311</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolliet</surname><given-names>P</given-names></name><name><surname>Tassaux</surname><given-names>D</given-names></name><name><surname>Thouret</surname><given-names>JM</given-names></name><name><surname>Chevrolet</surname><given-names>JC</given-names></name></person-group><article-title>Beneficial effects of helium:oxygen versus air:oxygen noninvasive pressure support in patients with decompensated chronic obstructive pulmonary disease</article-title><source>Crit Care Med</source><year>1999</year><volume>27</volume><issue>11</issue><fpage>2422</fpage><lpage>2429</lpage><pub-id pub-id-type="doi">10.1097/00003246-199911000-00017</pub-id><pub-id pub-id-type="pmid">10579259</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolliet</surname><given-names>P</given-names></name><name><surname>Tassaux</surname><given-names>D</given-names></name><name><surname>Roeseler</surname><given-names>J</given-names></name><name><surname>Burdet</surname><given-names>L</given-names></name><name><surname>Broccard</surname><given-names>A</given-names></name><name><surname>D'Hoore</surname><given-names>W</given-names></name><etal/></person-group><article-title>Helium-oxygen versus air-oxygen noninvasive pressure support in decompensated chronic obstructive disease: A prospective, multicenter study</article-title><source>Crit Care Med</source><year>2003</year><volume>31</volume><issue>3</issue><fpage>878</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000055369.37620.EE</pub-id><pub-id pub-id-type="pmid">12627000</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggiore</surname><given-names>SM</given-names></name><name><surname>Richard</surname><given-names>JC</given-names></name><name><surname>Abroug</surname><given-names>F</given-names></name><name><surname>Diehl</surname><given-names>JL</given-names></name><name><surname>Antonelli</surname><given-names>M</given-names></name><name><surname>Sauder</surname><given-names>P</given-names></name><etal/></person-group><article-title>A multicenter, randomized trial of noninvasive ventilation with helium-oxygen mixture in exacerbations of chronic obstructive lung disease</article-title><source>Crit Care Med</source><year>2010</year><volume>38</volume><issue>1</issue><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3181b78abe</pub-id><pub-id pub-id-type="pmid">19730250</pub-id></element-citation></ref></ref-list></back></article>